Cite
MLA Citation
François Doz et al.. “CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS.” Neuro-oncology, vol. 23, 2021, pp. vi73–vi74. http://access.bl.uk/ark:/81055/vdc_100146090265.0x00002f